Indaptus Therapeutics (INDP) Research & Development (2020 - 2026)
Indaptus Therapeutics (INDP) recorded Research & Development of $363,127 in Q2 2026, down 83.2% from $2.17 million a year earlier and down 26.1% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Indaptus Therapeutics' Research & Development came in at $5.22 million as of Jun 30, 2026, down 41.5% year-over-year; for FY2025, it was $9.34 million, up 28.8% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 28.6% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $7.25 million in FY2024 (-4.9%), $7.62 million in FY2023 (+20.5%), $6.32 million in FY2022 (+150.7%) and $2.52 million in FY2021 (-5.0%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2020.
- On a year-over-year basis, Research & Development rose in five of the last eight quarters, with an average decline of 7.1%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 285.1% in Q2 2022, against a decline of 83.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $491,134 (Q1 2026), $2.85 million (Q4 2025) and $1.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Indaptus Therapeutics | 210.93 Mn | 183.54 Mn | - | 363,127.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363,127.00 |
| Mar 31, 2026 | 491,134.00 |
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.81 Mn |
| Dec 31, 2024 | 2.48 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 944,641.00 |
| Sep 30, 2021 | 697,674.00 |
API Access
Indaptus Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();